Sichuan Biokin Pharmaceutical Co. Ltd. A (688506 SHG) stock market data APIs
¥262.6845
2.63(1%)
as of May 13, 2026
Try our APIs with
free plan!
Sichuan Biokin Pharmaceutical Co. Ltd. A Financial Data Overview
Price chart is built with
Anychart
Sichuan Biokin Pharmaceutical Co.,Ltd. engages in the research and development, production, and supply of biomedicine in the fields of antibody drug conjugate, guidance navigation and control, and antibody radionuclide conjugate in China and internationally. It offers anesthesia, parenteral nutrition, anti-infectives, pediatrics, and traditional Chinese medicines. The company was founded in 1996 and is headquartered in Chengdu, China.
Prev. Close
262.6845
Open
265.3148
High
267.6266
Low
258.613
52 wk Range
241.23-414.02
Market Cap
107 991 M
Shares Outstanding
413 M
Revenue
2 547 M
Beta
0.292
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Sichuan Biokin Pharmaceutical Co. Ltd. A data using free add-ons & libraries
Get Sichuan Biokin Pharmaceutical Co. Ltd. A Fundamental Data
Sichuan Biokin Pharmaceutical Co. Ltd. A Fundamental data includes:
- Net Revenue: 2 547 M
- EBITDA: -909 103 424
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Sichuan Biokin Pharmaceutical Co. Ltd. A Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-04-28
- EPS/Forecast: NaN
Get Sichuan Biokin Pharmaceutical Co. Ltd. A End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sichuan Biokin Pharmaceutical Co. Ltd. A News
New
SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer
Izalontamab brengitecan (Iza-bren) met its dual primary endpoints of progression free survival ("PFS") and overall survival ("OS") in an interim analysis of a Phase 3 trial (NCT06382142) conducted in ...
Biokin to Present at J.P. Morgan's 44th Annual Healthcare Conference
REDMOND, Wash., Jan. 13, 2026 /PRNewswire/ -- SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, today announced that its affiliate, Sichuan Biokin Pharmaceutical Co., Ltd. (Biokin)...
Chinese healthcare, biotech firms flock to Hong Kong for IPOs
Eleven Chinese healthcare and biotechnology companies filed applications to list on the Hong Kong stock exchange in the last two days of September, taking advantage of an ongoing investment boom in th...
Get Sichuan Biokin Pharmaceutical Co. Ltd. A fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
